[
  {
    "title": "BDX Shares May Climb as GalaFLEX LITE Trial Hits Key Milestone",
    "published": 1742826060,
    "posting_price": 230.16000366,
    "close_price": 228.61500549,
    "percent_change": -0.67127135
  },
  {
    "title": "Was Jim Cramer Right About Becton, Dickinson and Company (BDX)?",
    "published": 1742670915
  },
  {
    "title": "FDA tags Becton, Dickinson and Company infusion software recall as Class I",
    "published": 1742574330,
    "posting_price": 231.08999634,
    "close_price": 230.22999573,
    "percent_change": -0.37214965
  },
  {
    "title": "BD treats first subject in trial of bioabsorbable\u00a0scaffold",
    "published": 1742571090,
    "posting_price": 231.08999634,
    "close_price": 230.22999573,
    "percent_change": -0.37214965
  },
  {
    "title": "Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term",
    "published": 1742565906,
    "posting_price": 231.08999634,
    "close_price": 230.22999573,
    "percent_change": -0.37214965
  },
  {
    "title": "BD Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE\u2122 Scaffold in Breast Implant Revision Surgery",
    "published": 1742467800,
    "posting_price": 231.75,
    "close_price": 231.8500061,
    "percent_change": 0.04315258
  },
  {
    "title": "Here's Why Becton Dickinson (BDX) is a Strong Value Stock",
    "published": 1742391609,
    "posting_price": 231.19000244,
    "close_price": 231.78999329,
    "percent_change": 0.25952284
  },
  {
    "title": "Here's Why Becton Dickinson (BDX) is a Strong Momentum Stock",
    "published": 1742305808,
    "posting_price": 228.41000366,
    "close_price": 232.11999512,
    "percent_change": 1.62426838
  },
  {
    "title": "BD (NYSE:BDX): Strongest Q4 Results from the Surgical Equipment & Consumables - Diversified Group",
    "published": 1741597605,
    "posting_price": 228.49000549,
    "close_price": 227.44999695,
    "percent_change": -0.45516588
  },
  {
    "title": "Here's Why Becton Dickinson (BDX) is a Strong Growth Stock",
    "published": 1740753910,
    "posting_price": 224.1298803,
    "close_price": 224.50816345,
    "percent_change": 0.16877854
  },
  {
    "title": "3 Reasons to Sell BDX and 1 Stock to Buy Instead",
    "published": 1740733668,
    "posting_price": 224.1298803,
    "close_price": 224.50816345,
    "percent_change": 0.16877854
  },
  {
    "title": "Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term",
    "published": 1740667211,
    "posting_price": 225.97150753,
    "close_price": 223.14437866,
    "percent_change": -1.25109971
  },
  {
    "title": "BD business separation could allow competitors to rise in IVD test markets",
    "published": 1740047022,
    "posting_price": 226.7081667,
    "close_price": 226.89729309,
    "percent_change": 0.08342284
  },
  {
    "title": "Do Options Traders Know Something About BD (BDX) Stock We Don't?",
    "published": 1739885400,
    "posting_price": 222.19868631,
    "close_price": 224.10998535,
    "percent_change": 0.86017567
  },
  {
    "title": "BD to Present at Investor Healthcare Conferences",
    "published": 1739481300,
    "posting_price": 224.40861954,
    "close_price": 223.99052429,
    "percent_change": -0.1863098
  },
  {
    "title": "Are You a Value Investor? This 1 Stock Could Be the Perfect Pick",
    "published": 1739284811,
    "posting_price": 228.35068668,
    "close_price": 228.48010254,
    "percent_change": 0.05667417
  },
  {
    "title": "BD business split \u2018may prefigure\u2019 life sciences division selloff",
    "published": 1738950208,
    "posting_price": 228.11176839,
    "close_price": 228.80860901,
    "percent_change": 0.3054821
  },
  {
    "title": "Steris: Moving On, Losing Its Teeth",
    "published": 1713074165
  },
  {
    "title": "Here's Why You Should Hold BD (BDX) Stock in Your Portfolio",
    "published": 1712934240,
    "posting_price": 235.02244798,
    "close_price": 231.13046265,
    "percent_change": -1.65600578
  },
  {
    "title": "ClearBridge Appreciation Strategy Q1 2024 Portfolio Manager Commentary",
    "published": 1712753700,
    "posting_price": 239.16995701,
    "close_price": 236.85049438,
    "percent_change": -0.96979682
  },
  {
    "title": "BD Named a Best Employer for Excellence in Employee Well-Being",
    "published": 1712744021,
    "posting_price": 239.16995701,
    "close_price": 236.85049438,
    "percent_change": -0.96979682
  },
  {
    "title": "GSH Corporation Announces Director Retirement",
    "published": 1712638080,
    "posting_price": 238.50164405,
    "close_price": 241.58770752,
    "percent_change": 1.29393803
  },
  {
    "title": "BD's (BDX) Latest Product to Offer Wider Access to Researchers",
    "published": 1712586420,
    "posting_price": 241.39114329,
    "close_price": 237.56796265,
    "percent_change": -1.58381148
  },
  {
    "title": "YieldBoost Becton, Dickinson To 6.8% Using Options",
    "published": 1712572380,
    "posting_price": 241.39114329,
    "close_price": 237.56796265,
    "percent_change": -1.58381148
  },
  {
    "title": "BD Increases Access to Cutting-Edge Image-Enabled, Spectral Cell Sorters",
    "published": 1712560113,
    "posting_price": 241.39114329,
    "close_price": 237.56796265,
    "percent_change": -1.58381148
  },
  {
    "title": "ClearBridge Dividend Strategy Q1 2024 Portfolio Manager Commentary",
    "published": 1712385900
  },
  {
    "title": "AngioDynamics upgraded at Oppenheimer on pipeline progress",
    "published": 1712305200,
    "posting_price": 238.87512546,
    "close_price": 241.94152832,
    "percent_change": 1.28368446
  },
  {
    "title": "Becton Dickinson announes commercial release of cell sorters",
    "published": 1712296320,
    "posting_price": 238.87512546,
    "close_price": 241.94152832,
    "percent_change": 1.28368446
  },
  {
    "title": "BD to Announce Financial Results for its Second Quarter of Fiscal 2024",
    "published": 1712261700,
    "posting_price": 241.56804737,
    "close_price": 238.87512207,
    "percent_change": -1.11476883
  },
  {
    "title": "Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term",
    "published": 1712238011,
    "posting_price": 241.56804737,
    "close_price": 238.87512207,
    "percent_change": -1.11476883
  },
  {
    "title": "Citi opens 90-day catalyst watch on Becton Dickinson",
    "published": 1712212740,
    "posting_price": 241.56804737,
    "close_price": 238.87512207,
    "percent_change": -1.11476883
  },
  {
    "title": "Rich Returns at a Discount: 3 Dividend Aristocrats Trading at 52-Week Lows",
    "published": 1712191680,
    "posting_price": 241.56804737,
    "close_price": 238.87512207,
    "percent_change": -1.11476883
  },
  {
    "title": "BDX vs. MMSI: Which Stock Is the Better Value Option?",
    "published": 1712158811,
    "posting_price": 237.38122514,
    "close_price": 239.40583801,
    "percent_change": 0.85289511
  },
  {
    "title": "Citi opens 'positive catalyst watch' on Becton Dickinson into earnings",
    "published": 1712119680,
    "posting_price": 237.38122514,
    "close_price": 239.40583801,
    "percent_change": 0.85289511
  },
  {
    "title": "11 Magnificent Dividend Growth Stocks to Buy and Hold Forever",
    "published": 1712088765,
    "posting_price": 238.74734721,
    "close_price": 236.87998962,
    "percent_change": -0.782148
  },
  {
    "title": "AngioDynamics (ANGO) Settles Patent Litigations With BD",
    "published": 1712068320,
    "posting_price": 238.74734721,
    "close_price": 236.87998962,
    "percent_change": -0.782148
  },
  {
    "title": "AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement",
    "published": 1712044620,
    "posting_price": 238.74734721,
    "close_price": 236.87998962,
    "percent_change": -0.782148
  },
  {
    "title": "AngioDynamics settles all patent litigation with C.R. Bard",
    "published": 1711945920,
    "posting_price": 242.87519929,
    "close_price": 239.85794067,
    "percent_change": -1.24230824
  },
  {
    "title": "AngioDynamics settles litigation with Becton Dickinson",
    "published": 1711945320,
    "posting_price": 242.87519929,
    "close_price": 239.85794067,
    "percent_change": -1.24230824
  },
  {
    "title": "Should You Buy Solventum (SOLV) Stock After the 3M Spinoff?",
    "published": 1711933320,
    "posting_price": 242.87519929,
    "close_price": 239.85794067,
    "percent_change": -1.24230824
  }
]